![Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13046-020-1528-x/MediaObjects/13046_2020_1528_Fig7_HTML.png)
Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis | Journal of Experimental & Clinical Cancer Research | Full Text
![Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/418cc620-c469-44fe-b171-303cf50d488b/fx1_lrg.jpg)
Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib - Journal of Hepatology
![Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram](https://www.researchgate.net/publication/26767509/figure/fig2/AS:202820637728778@1425367616886/Mechanism-of-action-of-sorafenib-Sorafenib-exerts-a-dual-anticancer-effect-on-the-tumor.png)
Mechanism of action of sorafenib. Sorafenib exerts a dual anticancer... | Download Scientific Diagram
![Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics](https://mct.aacrjournals.org/content/molcanther/7/10/3129/F3.large.jpg)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics
![Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells - ScienceDirect Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006295220301301-ga1.jpg)
Dose-dependent regulation of mitochondrial function and cell death pathway by sorafenib in liver cancer cells - ScienceDirect
![Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics](https://mct.aacrjournals.org/content/molcanther/7/10/3129/F1.large.jpg)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | Molecular Cancer Therapeutics
![Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0223523419305975-gr2.jpg)
Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma - ScienceDirect
![Figure 4 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar Figure 4 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2f0e82390bcc2faa1bc6a700b06f5db1d5fa2283/7-Figure4-1.png)
Figure 4 from New knowledge of the mechanisms of sorafenib resistance in liver cancer | Semantic Scholar
Making sorafenib irresistible: <i>In vivo</i> screening for mechanisms of therapy resistance in hepatocellular carci
![Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram](https://www.researchgate.net/publication/260429966/figure/fig2/AS:271829853052928@1441820695259/Sorafenib-mechanism-of-action-tumor-proliferation-and-angiogenesis-Adapted-from-Mol.png)
Sorafenib mechanism of action: tumor proliferation and angiogenesis.... | Download Scientific Diagram
![Targeted therapy in HCC. Mechanisms of resistance to sorafenib in HCC... | Download Scientific Diagram Targeted therapy in HCC. Mechanisms of resistance to sorafenib in HCC... | Download Scientific Diagram](https://www.researchgate.net/profile/Gianluigi-Giannelli/publication/264164020/figure/fig1/AS:295984937619462@1447579717034/Targeted-therapy-in-HCC-Mechanisms-of-resistance-to-sorafenib-in-HCC-often-rely-on.png)
Targeted therapy in HCC. Mechanisms of resistance to sorafenib in HCC... | Download Scientific Diagram
![Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib | Journal of Experimental & Clinical Cancer Research | Full Text Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs13046-019-1216-x/MediaObjects/13046_2019_1216_Fig7_HTML.png)
Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib | Journal of Experimental & Clinical Cancer Research | Full Text
![New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Faps.2017.5/MediaObjects/41401_2017_Article_BFaps20175_Fig1_HTML.jpg)
New knowledge of the mechanisms of sorafenib resistance in liver cancer | Acta Pharmacologica Sinica
![An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells – lncRNA Blog An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells – lncRNA Blog](https://www.lncrnablog.com/wp-content/uploads/2016/10/mechanism.jpg)
An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells – lncRNA Blog
![Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells](https://www.medsci.org/v16/p1541/ijmsv16p1541g001.jpg)
Gold nanoparticles-loaded anti-miR221 enhances antitumor effect of sorafenib in hepatocellular carcinoma cells
![Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant hepatocellular carcinoma cells Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant hepatocellular carcinoma cells](https://i1.wp.com/www.zju.edu.cn/_upload/article/images/53/d5/a9cf9bb2420db3035a31dfadad6e/f8f94924-4962-4e28-a228-a5c3428935da.jpg?resize=640%2C449&ssl=1)
Scientists discover new transmission mechanism of exosome-mediated sorafenib-resistant hepatocellular carcinoma cells
![Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy](https://f6publishing.blob.core.windows.net/b82b12a8-8954-4c74-a1ce-33cc627db577/WJG-20-15269-g001.jpg)